Spots Global Cancer Trial Database for ingenol mebutate
Every month we try and update this database with for ingenol mebutate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | NCT02281682 | Keratosis, Acti... | Imiquimod 5-fluorouracil Ingenol mebutat... methylaminolevu... | 18 Years - | Maastricht University Medical Center | |
| PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy | NCT01449513 | Actinic Keratos... | Ingenol mebutat... Placebo Gel | 18 Years - | LEO Pharma | |
| Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis | NCT02242747 | Actinic Keratos... | ingenol mebutat... 5% 5-FU | 18 Years - | University of Sao Paulo | |
| Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp | NCT01836367 | Actinic Keratos... | Ingenol Mebutat... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions | NCT02124239 | Actinic Keratos... | Ingenol mebutat... | 18 Years - | LEO Pharma | |
| The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice | NCT02594436 | Actinic Keratos... | Ingenol mebutat... | 18 Years - | LEO Pharma | |
| Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions | NCT01735942 | Actinic Keratos... | Ingenol mebutat... cryotherapy | 18 Years - 89 Years | Northwestern University | |
| Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions | NCT01735942 | Actinic Keratos... | Ingenol mebutat... cryotherapy | 18 Years - 89 Years | Northwestern University | |
| Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis | NCT01998984 | Actinic Keratos... | ingenol mebutat... Placebo | 18 Years - | LEO Pharma | |
| Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy | NCT02990221 | Actinic Keratos... | Ingenol mebutat... cryotherapy | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice | NCT02594436 | Actinic Keratos... | Ingenol mebutat... | 18 Years - | LEO Pharma | |
| The Real Life Topical Field Treatment of Actinic Keratosis Study | NCT02362152 | Actinic Keratos... | Ingenol mebutat... 5-fluorouracil Imiquimod Diclofenac | 18 Years - | LEO Pharma | |
| PMS to Evaluate the Safety and Efficacy of Picato® Gel | NCT02421471 | Actinic Keratos... | Ingenol mebutat... | 19 Years - | LEO Pharma | |
| Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks | NCT02090465 | Actinic Keratos... | Ingenol Mebutat... | 18 Years - | LEO Pharma | |
| Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions | NCT02124239 | Actinic Keratos... | Ingenol mebutat... | 18 Years - | LEO Pharma | |
| TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction | NCT04202445 | Actinic Keratos... | Ingenol mebutat... | 18 Years - | LEO Pharma |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
